and a 36-month beta value of 1.01. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 6 as “hold,” and 0 as “sell.”
The average price predicted for Bausch Health Companies Inc. (BHC) by analysts is $9.00, which is $5.7 above the current market price. The public float for BHC is 344.64M, and at present, short sellers hold a 7.98% of that float. On March 16, 2023, the average trading volume of BHC was 5.75M shares.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
BHC) stock’s latest price update
Bausch Health Companies Inc. (NYSE: BHC)’s stock price has decreased by -3.66 compared to its previous closing price of 7.92. Despite this, the company has seen a fall of -11.48% in its stock price over the last five trading days. The Wall Street Journal reported on 01/13/22 that Eye-Care Company Bausch & Lomb Files for IPO
BHC’s Market Performance
Bausch Health Companies Inc. (BHC) has experienced a -11.48% fall in stock performance for the past week, with a 4.23% rise in the past month, and a -0.26% drop in the past quarter. The volatility ratio for the week is 4.13%, and the volatility levels for the past 30 days are at 5.72% for BHC. The simple moving average for the last 20 days is -13.54% for BHC stock, with a simple moving average of 2.63% for the last 200 days.
Analysts’ Opinion of BHC
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see BHC reach a price target of $5, previously predicting the price at $12. The rating they have provided for BHC stocks is “Sector Perform” according to the report published on July 29th, 2022.
BHC Trading at -5.82% from the 50-Day Moving Average
After a stumble in the market that brought BHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.55% of loss for the given period.
Volatility was left at 5.72%, however, over the last 30 days, the volatility rate increased by 4.13%, as shares surge +1.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +21.50% upper at present.
During the last 5 trading sessions, BHC fell by -11.48%, which changed the moving average for the period of 200-days by -22.62% in comparison to the 20-day moving average, which settled at $8.83. In addition, Bausch Health Companies Inc. saw 21.50% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at BHC starting from Carson Seana, who sale 292 shares at the price of $9.32 back on Feb 28. After this action, Carson Seana now owns 359,185 shares of Bausch Health Companies Inc., valued at $2,721 using the latest closing price.
Bausch Health Companies Inc., the 10% Owner of Bausch Health Companies Inc., sale 4,550,357 shares at $17.05 during a trade that took place back on Jun 01, which means that Bausch Health Companies Inc. is holding 310,449,643 shares at $77,606,339 based on the most recent closing price.
Stock Fundamentals for BHC
Current profitability levels for the company are sitting at:
- +17.12 for the present operating margin
- +55.95 for the gross margin
The net margin for Bausch Health Companies Inc. stands at -2.77. Equity return is now at value 42.30, with -0.80 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.08.
Conclusion
To sum up, Bausch Health Companies Inc. (BHC) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
